Ascension set to take control of Presence Health

By Jonathan Dyble
Non-profit health company Ascension revealed this week the signing of a non-binding letter of intent for fellow US-based Presence Health to join the com...

Non-profit health company Ascension revealed this week the signing of a non-binding letter of intent for fellow US-based Presence Health to join the company in an acquisition that would make it part of Ascension’s AMITA Health Group.

If the transaction goes ahead, Presence Health’s medical centres and other facilities would be integrated into AMITA Health’s network, a joint venture between Ascension’s Alexian Brothers Health System and Adventist Midwest Health.

“The mission, values and history of Presence Health clearly align well with those of Ascension, as both systems are dedicated to caring for all, with special attention to persons living in poverty and those most vulnerable,” said Ascension’s CEO Anthony Tersigni.

“We believe this will strengthen Catholic healthcare not only in the region but throughout the country as we are all dedicated to delivering personalised, compassionate care.”

See also:

With AMITA Health and Presence Health holding similar core principals of faith-based healthcare, the merger would bolster the former’s standings as one of America’s largest hospital systems, something that AMITA Health CEO Mark Frey has expressed his satisfaction towards.

“Since we brought together Alexian Brothers Health System and Adventist Midwest Health to form AMITA Health two years ago, we’ve always looked for opportunities to add like-minded partners with similar values to our system,” he said.

“Bringing Presence Health into Ascension and AMITA Health is a perfect fit and an exciting continuation of our commitment to increase access to quality healthcare in the many communities we serve.”

Through this venture of expansion, AMITA Health will increase citizens’ access to healthcare and deepen specialisation, providing both improved quality and quantity to patients, with the deal expected to complete in early 2018.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare